Market Research Report
Global Myasthenia Gravis Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
|Published by||QYResearch||Product code||750046|
|Published||Content info||127 Pages
Delivery time: 3-5 business days
|Global Myasthenia Gravis Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025|
|Published: November 29, 2018||Content info: 127 Pages||
Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenance.
The market is witnessing the rapid development of novel drugs such as monoclonal antibodies, which is one of the primary factors driving this market's growth prospects. Most drug manufacturers are increasingly focussing on the development of monoclonal antibodies, as they act specifically on target cells; thereby, leading to lower side effects. Since conventional therapies such as acetylcholinesterase inhibitor, oral steroids, and immunomodulatory agents are associated with more side effects, physicians prefer to prescribe high efficacious monoclonal antibodies.
In 2018, the global Myasthenia Gravis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Myasthenia Gravis Drugs.
This study researches the market size of Myasthenia Gravis Drugs, presents the global Myasthenia Gravis Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Myasthenia Gravis Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Myasthenia Gravis Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
In this study, the years considered to estimate the market size of Myasthenia Gravis Drugs are as follows: